Somnomed Share Price and Company Fundamentals
Last traded: Today at 4:02 AM
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Key Metrics
PE ratio
-
PB ratio
3.05
Dividend yield
-
Beta
0.92
Market cap
$143.08M
Enterprise value
$131.20M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://somnomed.com/au/ |
| Mailing address | 20 Clarke Street Level 3 Crows Nest NSW 2065 Australia |
| Phone / Fax | 61 2 9467 0400 / 61 2 9467 0467 |
Dividends
More: Somnomed Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Somnomed paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SOM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Somnomed.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Amrita Blickstead BME, M.B.A. | Co-CEO & Executive Director | ||
| Ms. Karen Borg B.A. | Co-CEO & Executive Director | ||
| Ms. Ye-Fei Guo | Chief Financial Officer | ||
| Mr. Jonathan Vowels | Vice President of Manufacturing & Operations | ||
| Mr. David Lewis | Chief Information Officer | ||
| Ms. Janice Hiskett-Jones | Chief People Officer | ||
| Mr. Marco Van Kleef | President of Europe | ||
| Mr. Keshan Gunasinghe | Chief Product Officer | ||
| Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN | Company Secretary | 66 | |
| Mr. Christopher Bedford | Vice President of Global Production and Product Development |
Profitability and management effectiveness
Profit margin
-3.10%
Operating margin
-2.99%
Return on assets
-0.26%
Return on equity
-7.56%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Somnomed is 143.08M and its enterprise value is 131.20M. The enterprise value to revenue ratio of SOM is 1.18. The enterprise value to EBITDA ratio of SOM is 82.86.
The SOM's stocks Beta value is 0.92 making it 8% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Somnomed (SOM)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Somnomed (ASX:SOM) Frequently Asked Questions
1. What is Somnomed's Stock Symbol?
Somnomed trades on ASX under the ticker symbol "SOM".
2. What is Somnomed's stock price today?
One share of SOM stock can currently be purchased for approximately $0.655.
3. How can I contact Somnomed?
Somnomed's mailing address is 20 Clarke Street Level 3 Crows Nest NSW 2065 Australia. The company can be reached via phone at 61 2 9467 0400.
4. What is Somnomed's official website?
The official website of Somnomed is https://somnomed.com/au/.